A Not-So-Transparent Attempt to Cap Drug Prices

via Wall Street Journal

At the dawn of the 20th century, life expectancy in the United States was 47 years. Today, it’s 79. Two decades ago, a diagnosis of HIV/AIDS or hepatitis C was a death sentence. The mortality rate from AIDS has since dropped 85%, to fewer than 7,000 deaths a year from 44,000. Hepatitis C cure rates have reached 90%.

These stunning improvements are the result of medical and scientific advances. If they continue, we could someday solve the riddle of such scourges as Alzheimer’s and cancer.

Why, then, are some people so willing to jeopardize if not halt this progress? It’s a question that those who seek to vilify pharmaceutical companies need to answer…

To read the full article CLICK HERE

Advertisements

About thebenefitblog

Eric is a Producer at Lockton Insurance Brokers, Inc., the world’s largest privately held commercial broker. Eric has over 23 years of experience in the insurance industry and has spent the last 11 years with Lockton. Eric specializes in Health & Welfare Benefits, Retirement Planning, and Executive Benefits. Eric's clients utilize his expertise in the areas of Plan Due Diligence, Transaction Structure, Fiduciary Oversight, Investment Design, Compliance and Vendor negotiation to improve the operational & financial outcome for each client. The Benefit Blog is a place to share that expertise and industry news.
This entry was posted in Uncategorized. Bookmark the permalink.